Cipla, Dr Reddy’s Lab, Mondelez & Unilever lauded for transition to fourth industrial revolution using advanced technologies despite global challenges like Ukraine war & Covid.
Dr Reddy's, through which Russia's Sputnik V is available in India, said the timeline was pushed a little further due to import dependency, quality checks.
Originally intended for cancer, Dr Reddy’s 2-DG works by preventing the supply of glucose molecules to cancerous cells, which need glucose for survival.
The drug was tested on 40 patients during phase 2 trials. But, the govt’s expert panel found the sample size ‘inadequate’ to approve the drug for marketing in India.
Dr Reddy’s had proposed to test Sputnik V in a Phase III clinical trial that generally needs to enroll over 1,000 participants. Govt panel has recommended a smaller trial instead.
RDIF will supply 100 million doses of Sputnik V — the Covid vaccine developed by Russian researchers — in India once it has received all the regulatory clearances.
French newspaper La Tribune earlier last week indicated that UAE withdrew from deal to fund EUR 3.5 billion. India is looking to order 114 new Rafales, which could include the F5.
China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.
COMMENTS